AKT1 and breast carcinoma: As highlighted previously, the Akt pathway is central to the malignancy of various breast cancer cells, and thus, the inhibition of the pathway, as seen in the case of the CGA and CA combination, is an effective target to arrest the malignancy and metastasis of breast cancer cells.